1. Home
  2. TNDM vs NAVI Comparison

TNDM vs NAVI Comparison

Compare TNDM & NAVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNDM
  • NAVI
  • Stock Information
  • Founded
  • TNDM 2006
  • NAVI 1973
  • Country
  • TNDM United States
  • NAVI United States
  • Employees
  • TNDM 2650
  • NAVI N/A
  • Industry
  • TNDM Medical/Dental Instruments
  • NAVI Investment Bankers/Brokers/Service
  • Sector
  • TNDM Health Care
  • NAVI Finance
  • Exchange
  • TNDM Nasdaq
  • NAVI Nasdaq
  • Market Cap
  • TNDM 1.1B
  • NAVI N/A
  • IPO Year
  • TNDM 2013
  • NAVI N/A
  • Fundamental
  • Price
  • TNDM $16.86
  • NAVI $11.21
  • Analyst Decision
  • TNDM Buy
  • NAVI Hold
  • Analyst Count
  • TNDM 16
  • NAVI 7
  • Target Price
  • TNDM $44.44
  • NAVI $13.43
  • AVG Volume (30 Days)
  • TNDM 1.5M
  • NAVI 856.0K
  • Earning Date
  • TNDM 04-30-2025
  • NAVI 04-30-2025
  • Dividend Yield
  • TNDM N/A
  • NAVI 5.70%
  • EPS Growth
  • TNDM N/A
  • NAVI N/A
  • EPS
  • TNDM N/A
  • NAVI 1.18
  • Revenue
  • TNDM $940,203,000.00
  • NAVI $848,000,000.00
  • Revenue This Year
  • TNDM $8.59
  • NAVI N/A
  • Revenue Next Year
  • TNDM $10.87
  • NAVI $0.14
  • P/E Ratio
  • TNDM N/A
  • NAVI $9.50
  • Revenue Growth
  • TNDM 25.74
  • NAVI N/A
  • 52 Week Low
  • TNDM $15.75
  • NAVI $10.53
  • 52 Week High
  • TNDM $53.69
  • NAVI $16.97
  • Technical
  • Relative Strength Index (RSI)
  • TNDM 33.57
  • NAVI 38.27
  • Support Level
  • TNDM $16.30
  • NAVI $10.99
  • Resistance Level
  • TNDM $17.73
  • NAVI $11.41
  • Average True Range (ATR)
  • TNDM 1.11
  • NAVI 0.64
  • MACD
  • TNDM 0.28
  • NAVI -0.04
  • Stochastic Oscillator
  • TNDM 29.92
  • NAVI 27.09

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Share on Social Networks: